US Edition
Published • loading... • Updated
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring A 10.35% Potential Upside
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring A 10.35% Potential Upside
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, has attracted attention for its promising potential upside of 10.35%. Specializing in both generic and proprietary injectable, inhalation, and intranasal products, this biopharmaceutical company serves crucial markets in the United States, China, and France. With a market capitalization of $1.33 billion, Amphastar’s strategic growth and diverse product offerin…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
